Hatch Biofund is an early stage, life sciences venture capital firm headquartered in the Philadelphia region, one of the fastest-growing biotech hubs in the world. We invest exclusively in private companies developing therapeutics and vaccines for human use across all treatment modalities, from small molecules to cell and gene therapy. We are partial to capital efficiency, clear development pathways, and experimental medicines that promise to bring great value to society.
Looking for a particular Hatch Biofund Management employee's phone or email?
The Hatch Biofund Management annual revenue was $2 million in 2026.
1 people are employed at Hatch Biofund Management.
Hatch Biofund Management is based in Doylestown, Pennsylvania.
The NAICS codes for Hatch Biofund Management are [5417, 541713, 54, 54171, 541].
The SIC codes for Hatch Biofund Management are [873, 87].